Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Welch

Showing results (121-130 of 183) with videos related to

Pageof 19
Sort By:
Cancer Research|January 26, 2002
Copper-64-pyruvaldehyde-bis(N(4)-methylthiosemicarbazone) for the prevention of tumor growth at wound sites following laparoscopic surgery: monitoring therapy response with microPET and magnetic resonance imagingJason S Lewis, Judith M Connett, Joel R Garbow, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 4, 2011
Targeting angiogenesis using a C-type atrial natriuretic factor-conjugated nanoprobe and PETYongjian Liu, Eric D Pressly, Dana R Abendschein, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 15, 2003
In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSMFarrokh Dehdashti, Mark A Mintun, Jason S Lewis, et al.
Nuclear Medicine and Biology|February 17, 2009
Preparation and evaluation of ethyl [(18)F]fluoroacetate as a proradiotracer of [(18)F]fluoroacetate for the measurement of glial metabolism by PETTetsuya Mori, Li-Quan Sun, Masato Kobayashi, et al.
Nuclear Medicine and Biology|February 15, 2011
Internal radiotherapy with copper-64-diacetyl-bis (N4-methylthiosemicarbazone) reduces CD133+ highly tumorigenic cells and metastatic ability of mouse colon carcinomaYukie Yoshii, Takako Furukawa, Yasushi Kiyono, et al.
ACS Nano|May 3, 2012
64Cu Core-labeled nanoparticles with high specific activity via metal-free click chemistryDexing Zeng, Nam S Lee, Yongjian Liu, et al.
Breast Cancer Research and Treatment|March 11, 2008
PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancerFarrokh Dehdashti, Joanne E Mortimer, Kathryn Trinkaus, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 3, 2007
18F-fluoroacetate: a potential acetate analog for prostate tumor imaging--in vivo evaluation of 18F-fluoroacetate versus 11C-acetateDatta E Ponde, Carmen S Dence, Nobuyuki Oyama, et al.
Nuclear Medicine and Biology|September 2, 2009
Tumor uptake of radiolabeled acetate reflects the expression of cytosolic acetyl-CoA synthetase: implications for the mechanism of acetate PETYukie Yoshii, Atsuo Waki, Takako Furukawa, et al.
Journal of Medicinal Chemistry|November 24, 2005
N-benzylisatin sulfonamide analogues as potent caspase-3 inhibitors: synthesis, in vitro activity, and molecular modeling studiesWenhua Chu, Jun Zhang, Chenbo Zeng, et al.
Pageof 19

Showing results (121-130 of 183) with videos related to

Sort By:
Pageof 19
Cancer Research|January 26, 2002
Copper-64-pyruvaldehyde-bis(N(4)-methylthiosemicarbazone) for the prevention of tumor growth at wound sites following laparoscopic surgery: monitoring therapy response with microPET and magnetic resonance imagingJason S Lewis, Judith M Connett, Joel R Garbow, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 4, 2011
Targeting angiogenesis using a C-type atrial natriuretic factor-conjugated nanoprobe and PETYongjian Liu, Eric D Pressly, Dana R Abendschein, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 15, 2003
In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSMFarrokh Dehdashti, Mark A Mintun, Jason S Lewis, et al.
Nuclear Medicine and Biology|February 17, 2009
Preparation and evaluation of ethyl [(18)F]fluoroacetate as a proradiotracer of [(18)F]fluoroacetate for the measurement of glial metabolism by PETTetsuya Mori, Li-Quan Sun, Masato Kobayashi, et al.
Nuclear Medicine and Biology|February 15, 2011
Internal radiotherapy with copper-64-diacetyl-bis (N4-methylthiosemicarbazone) reduces CD133+ highly tumorigenic cells and metastatic ability of mouse colon carcinomaYukie Yoshii, Takako Furukawa, Yasushi Kiyono, et al.
ACS Nano|May 3, 2012
64Cu Core-labeled nanoparticles with high specific activity via metal-free click chemistryDexing Zeng, Nam S Lee, Yongjian Liu, et al.
Breast Cancer Research and Treatment|March 11, 2008
PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancerFarrokh Dehdashti, Joanne E Mortimer, Kathryn Trinkaus, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 3, 2007
18F-fluoroacetate: a potential acetate analog for prostate tumor imaging--in vivo evaluation of 18F-fluoroacetate versus 11C-acetateDatta E Ponde, Carmen S Dence, Nobuyuki Oyama, et al.
Nuclear Medicine and Biology|September 2, 2009
Tumor uptake of radiolabeled acetate reflects the expression of cytosolic acetyl-CoA synthetase: implications for the mechanism of acetate PETYukie Yoshii, Atsuo Waki, Takako Furukawa, et al.
Journal of Medicinal Chemistry|November 24, 2005
N-benzylisatin sulfonamide analogues as potent caspase-3 inhibitors: synthesis, in vitro activity, and molecular modeling studiesWenhua Chu, Jun Zhang, Chenbo Zeng, et al.
Pageof 19